Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation

Journal of Pharmacology and Experimental Therapeutics

Volumn 271, Issue 1, 1994, Pages 557-566

  Thummel, K E ^a   Shen, D D ^a   Podoll, T D ^a   Kunze, K L ^a   Trager, W F ^a   Bacchi, C E ^a   Marsh, C L ^a   McVicar, J P ^a   Barr, D M ^a   Perkins, J D ^a   Carithers Jr , R L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXYMIDAZOLAM; CYCLOSPORIN; CYTOCHROME P450; DEXAMETHASONE; MIDAZOLAM; PENTOBARBITAL; PHENYTOIN;

ARTICLE; CATALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; LIVER BIOPSY; LIVER TRANSPLANTATION; MICHAELIS CONSTANT; ORGAN DONOR; PRIORITY JOURNAL; RECIPIENT;

ADOLESCENT; ADULT; CHILD; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; MIDAZOLAM; MIDDLE AGED; MIXED FUNCTION OXYGENASES; PHENYTOIN; TISSUE DONORS;

EID: 0027985506     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)